Consilience Ventures

Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Our co-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. The team has grown to contain commercial expertise that encompasses individuals with a unicon exit in their CV's, as well as multiple startup experience between them. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients.

Jiva is a UK-based artificial intelligence company focused on revolutionizing the development of machine learning models through its innovative multimodal AI platform. This platform utilizes a process known as model fusion, which allows for the independent development of partial models that can later be combined to enhance overall performance. Jiva aims to create practical diagnostic solutions for human diseases, with specific applications in areas such as prostate cancer MRI analysis, liver disease diagnosis, and bone fracture identification. By providing tools that enable users, including non-technical individuals, to aggregate, process, and analyze data, Jiva facilitates the iterative growth and deployment of models tailored for real-world healthcare challenges.

Cerebreon Technologies Ltd., founded in 2016 and headquartered in Portnoo, Ireland, develops software products specifically for the insolvency market. The company focuses on advanced data analytics, business management systems, and process automation. It offers bespoke software solutions and expert consultancy services, aiming to make high-end analytics accessible to businesses of all sizes and sectors. Through its innovative approach, Cerebreon Technologies supports enterprises in enhancing their operational efficiency and decision-making processes.